{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:49:16Z","timestamp":1763567356046,"version":"3.45.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Deanship of Graduate Studies and Scientific Research, Jazan University","award":["GSSRD-24"],"award-info":[{"award-number":["GSSRD-24"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. King Saud Univ. Comput. Inf. Sci."],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s44443-025-00003-8","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:06:25Z","timestamp":1761120385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MoX: an explainable hybrid deep-learning model for integrating multi-omics data to predict event-free survival in neuroblastoma prognosis"],"prefix":"10.1007","volume":"37","author":[{"given":"CKishor Kumar","family":"Reddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaya Sindhoori","family":"Kaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Advaitha","family":"Daduvy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Shuaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5982-5937","authenticated-orcid":false,"given":"Faisal","family":"Alshanketi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadab","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"1","key":"3_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13062-018-0223-8\/TABLES\/5","volume":"13","author":"I Baali","year":"2018","unstructured":"Baali I, Acar DAE, Aderinwale TW, HafezQorani S, Kazan H (2018) Predicting clinical outcomes in neuroblastoma with genomic data integration. Biol Direct 13(1):1\u201314. https:\/\/doi.org\/10.1186\/S13062-018-0223-8\/TABLES\/5","journal-title":"Biol Direct"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13062-018-0223-8","volume":"13","author":"I Baali","year":"2018","unstructured":"Baali I, Acar DAE, Aderinwale TW, HafezQorani S, Kazan H (2018) Predicting clinical outcomes in neuroblastoma with genomic data integration. Biology Direct 13:1\u201314. https:\/\/doi.org\/10.1186\/s13062-018-0223-8","journal-title":"Biology Direct"},{"key":"3_CR3","unstructured":"Board PPTE (2024) \u201cNeuroblastoma Treatment (PDQ\u00ae),\u201d Pdq, no. Md, pp. 1\u201381, Apr. 2024, Accessed: Sep. 14, 2024. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK65747\/"},{"issue":"1","key":"3_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/CNCR.29706","volume":"122","author":"KR Bosse","year":"2016","unstructured":"Bosse KR, Maris JM (2016) Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations. Cancer 122(1):20\u201333. https:\/\/doi.org\/10.1002\/CNCR.29706","journal-title":"Cancer"},{"issue":"1","key":"3_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/cncr.29706","volume":"122","author":"KR Bosse","year":"2016","unstructured":"Bosse KR, Maris JM (2016) Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations. Cancer 122(1):20\u201333","journal-title":"Cancer"},{"issue":"12","key":"3_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/S12859-016-1194-3\/TABLES\/4","volume":"17","author":"D Cangelosi","year":"2016","unstructured":"Cangelosi D et al (2016) Artificial neural network classifier predicts neuroblastoma patients\u2019 outcome. BMC Bioinformatics 17(12):83\u201393. https:\/\/doi.org\/10.1186\/S12859-016-1194-3\/TABLES\/4","journal-title":"BMC Bioinformatics"},{"key":"3_CR7","unstructured":"Chen W-M, Fang Y-Y, Lin P, Bai J-X, Fang Y-F, Zhang B (2023) \u201cA novel nomogram for predicting post-recurrence survival in recurrent neuroblastoma patients,\u201d Am J Cancer Res 13(6):2254, Accessed: Sep. 14, 2024. [Online]. Available: \/pmc\/articles\/PMC10326575\/"},{"issue":"10","key":"3_CR8","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/JAMA.2012.228","volume":"307","author":"NKV Cheung","year":"2012","unstructured":"Cheung NKV et al (2012) Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma. JAMA 307(10):1062\u20131071. https:\/\/doi.org\/10.1001\/JAMA.2012.228","journal-title":"JAMA"},{"key":"3_CR9","doi-asserted-by":"publisher","unstructured":"Cornero A et al (2012) \u201cDesign of a multi-signature ensemble classifier predicting neuroblastoma patients\u2019 outcome,\u201d BMC Bioinformatics 13 https:\/\/doi.org\/10.1186\/1471-2105-13-S4-S13.","DOI":"10.1186\/1471-2105-13-S4-S13"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1158\/1078-0432.CCR-09-2607","volume":"16","author":"K De Preter","year":"2010","unstructured":"De Preter K et al (2010) Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature. Clin Cancer Res 16:1532\u20131541. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-2607","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-024-48363-5","volume":"15","author":"RJ Deyell","year":"2024","unstructured":"Deyell RJ et al (2024) \u201cWhole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers.\u201d Nature Commun 15(1):1\u201315. https:\/\/doi.org\/10.1038\/s41467-024-48363-5","journal-title":"Nature Commun"},{"issue":"8","key":"3_CR12","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ng.3333","volume":"47","author":"TF Eleveld","year":"2015","unstructured":"Eleveld TF et al (2015) Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations. Nature Genetics 47(8):864\u2013871. https:\/\/doi.org\/10.1038\/ng.3333","journal-title":"Nature Genetics"},{"key":"3_CR13","doi-asserted-by":"publisher","unstructured":"Francescatto M, Chierici M, Dezfooli SR, Zandon\u00e0 A, Jurman G, Furlanello C (2018) \u201cMulti-omics integration for neuroblastoma clinical endpoint prediction,\u201d Biol Direct 13 https:\/\/doi.org\/10.1186\/s13062-018-0207-8.","DOI":"10.1186\/s13062-018-0207-8"},{"issue":"7","key":"3_CR14","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1200\/JCO.2008.16.0630","volume":"27","author":"I Janoueix-Lerosey","year":"2009","unstructured":"Janoueix-Lerosey I et al (2009) Overall genomic pattern is a predictor of outcome in neuroblastoma. J Clin Oncol 27(7):1026\u20131033. https:\/\/doi.org\/10.1200\/JCO.2008.16.0630","journal-title":"J Clin Oncol"},{"issue":"2","key":"3_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1148\/radiol.14131691","volume":"272","author":"R Jain","year":"2014","unstructured":"Jain R et al (2014) Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. Radiology 272(2):484\u2013493. https:\/\/doi.org\/10.1148\/radiol.14131691","journal-title":"Radiology"},{"key":"3_CR16","doi-asserted-by":"publisher","unstructured":"Han Y et al (2019) \u201cIntegration of molecular features with clinical information for predicting outcomes for neuroblastoma patients,\u201d Biol Direct, 14 https:\/\/doi.org\/10.1186\/s13062-019-0244-y.","DOI":"10.1186\/s13062-019-0244-y"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"1208531","DOI":"10.3389\/FONC.2023.1208531\/BIBTEX","volume":"13","author":"R Hu","year":"2023","unstructured":"Hu R, Zhang Y, Liu S, Lee P, Liu C, Liu A (2023) Prognostic prediction by 18F-FDG-PET\/CT parameters in patients with neuroblastoma: a systematic review and meta-analysis. Front Oncol 13:1208531. https:\/\/doi.org\/10.3389\/FONC.2023.1208531\/BIBTEX","journal-title":"Front Oncol"},{"issue":"1","key":"3_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/J.PCL.2014.09.015","volume":"62","author":"MS Irwin","year":"2015","unstructured":"Irwin MS, Park JR (2015) Neuroblastoma: Paradigm for Precision Medicine. Pediatr Clin North Am 62(1):225\u2013256. https:\/\/doi.org\/10.1016\/J.PCL.2014.09.015","journal-title":"Pediatr Clin North Am"},{"issue":"7484","key":"3_CR19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence MS et al (2014) Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505(7484):496\u2013501. https:\/\/doi.org\/10.1038\/nature12912","journal-title":"Nature"},{"issue":"38","key":"3_CR20","doi-asserted-by":"publisher","first-page":"E34925","DOI":"10.1097\/MD.0000000000034925","volume":"102","author":"M Li","year":"2023","unstructured":"Li M, Duan X, Li C, You D, Liu L (2023) A novel clinical tool and risk stratification system for predicting the event-free survival of neuroblastoma patients: A TARGET-based study. Medicine (United States) 102(38):E34925. https:\/\/doi.org\/10.1097\/MD.0000000000034925","journal-title":"Medicine (United States)"},{"issue":"12","key":"3_CR21","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.3390\/CANCERS14122874","volume":"14","author":"X Li","year":"2022","unstructured":"Li X et al (2022) The machine-learning-mediated interface of microbiome and genetic risk stratification in neuroblastoma reveals molecular pathways related to patient survival. Cancers 14(12):2874. https:\/\/doi.org\/10.3390\/CANCERS14122874","journal-title":"Cancers"},{"issue":"3","key":"3_CR22","doi-asserted-by":"publisher","first-page":"e0230536","DOI":"10.1371\/JOURNAL.PONE.0230536","volume":"15","author":"G L\u00f3pez-Garc\u00eda","year":"2020","unstructured":"L\u00f3pez-Garc\u00eda G, Jerez JM, Franco L, Veredas FJ (2020) Transfer learning with convolutional neural networks for cancer survival prediction using gene-expression data. PLoS ONE 15(3):e0230536. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0230536","journal-title":"PLoS ONE"},{"key":"3_CR23","unstructured":"Mahapatra S, Challagundla KB (2023) \u201cNeuroblastoma,\u201d StatPearls, Accessed: Sep. 14, 2024. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448111\/"},{"key":"3_CR24","doi-asserted-by":"publisher","unstructured":"Mobadersany P et al (2017) \u201cPredicting cancer outcomes from histology and genomics using convolutional networks,\u201d Proc Natl Acad Sci U S A 115 https:\/\/doi.org\/10.1073\/pnas.1717139115.","DOI":"10.1073\/pnas.1717139115"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"7391","DOI":"10.1038\/nature10910","volume":"483","author":"JJ Molenaar","year":"2012","unstructured":"Molenaar JJ et al (2012) Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483:7391. https:\/\/doi.org\/10.1038\/nature10910","journal-title":"Nature"},{"issue":"4","key":"3_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/PBC.24777","volume":"61","author":"YP Moss\u00e9","year":"2014","unstructured":"Moss\u00e9 YP et al (2014) Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group project. Pediatr Blood Cancer 61(4):627\u2013635. https:\/\/doi.org\/10.1002\/PBC.24777","journal-title":"Pediatr Blood Cancer"},{"key":"3_CR27","doi-asserted-by":"publisher","unstructured":"Nohara Y, Matsumoto K, Soejima H, Nakashima N (2019) \u201cExplanation of Machine Learning Models Using Improved Shapley Additive Explanation,\u201d pp. 546\u2013546 https:\/\/doi.org\/10.1145\/3307339.3343255.","DOI":"10.1145\/3307339.3343255"},{"issue":"21","key":"3_CR28","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1200\/JCO.2009.27.3367\/ASSET\/IMAGES\/ZLJ9991002540004.JPEG","volume":"28","author":"A Oberthuer","year":"2010","unstructured":"Oberthuer A et al (2010) Prognostic impact of gene expression-based classification for neuroblastoma. J Clin Oncol 28(21):3506\u20133515. https:\/\/doi.org\/10.1200\/JCO.2009.27.3367\/ASSET\/IMAGES\/ZLJ9991002540004.JPEG","journal-title":"J Clin Oncol"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1158\/1078-0432.CCR-14-0817","volume":"21","author":"A Oberthuer","year":"2014","unstructured":"Oberthuer A et al (2014) Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers. Clin Cancer Res 21:1904\u20131915. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0817","journal-title":"Clin Cancer Res"},{"issue":"20","key":"3_CR30","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.1158\/1078-0432.CCR-07-4377","volume":"14","author":"A Oberthuer","year":"2008","unstructured":"Oberthuer A et al (2008) Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR. Clin Cancer Res 14(20):6590\u20136601. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4377","journal-title":"Clin Cancer Res"},{"issue":"8","key":"3_CR31","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.3390\/IJMS21082714","volume":"21","author":"GG Olivera","year":"2020","unstructured":"Olivera GG et al (2020) \u201cMTHFR and VDR polymorphisms improve the prognostic value of MYCN status on overall survival in neuroblastoma patients.\u201d Int J Mol Sci 21(8):2714. https:\/\/doi.org\/10.3390\/IJMS21082714","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3_CR32","doi-asserted-by":"publisher","first-page":"e1006501","DOI":"10.1371\/JOURNAL.PGEN.1006501","volume":"12","author":"OM Padovan-Merhar","year":"2016","unstructured":"Padovan-Merhar OM et al (2016) Enrichment of targetable mutations in the relapsed neuroblastoma genome. PLoS Genet 12(12):e1006501. https:\/\/doi.org\/10.1371\/JOURNAL.PGEN.1006501","journal-title":"PLoS Genet"},{"issue":"1","key":"3_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/PBC.21784","volume":"52","author":"JR Park","year":"2009","unstructured":"Park JR et al (2009) Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the children\u2019s oncology group. Pediatr Blood Cancer 52(1):44. https:\/\/doi.org\/10.1002\/PBC.21784","journal-title":"Pediatr Blood Cancer"},{"key":"3_CR34","unstructured":"Pears R, Finlay J, Connor AM (2014) \u201cSynthetic Minority Over-sampling TEchnique(SMOTE) for Predicting Software Build Outcomes,\u201d Proceedings of the International Conference on Software Engineering and Knowledge Engineering, SEKE, 546\u2013551, Accessed: Sep. 14, 2024. [Online]. Available: https:\/\/arxiv.org\/abs\/1407.2330v1"},{"issue":"22","key":"3_CR35","doi-asserted-by":"publisher","first-page":"8431","DOI":"10.1073\/PNAS.0401736101\/SUPPL_FILE\/01736FIG7.PDF","volume":"101","author":"J Pittman","year":"2004","unstructured":"Pittman J et al (2004) Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc Natl Acad Sci U S A 101(22):8431\u20138436. https:\/\/doi.org\/10.1073\/PNAS.0401736101\/SUPPL_FILE\/01736FIG7.PDF","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ng.2529","volume":"45","author":"TJ Pugh","year":"2013","unstructured":"Pugh TJ et al (2013) (2013) \u201cThe genetic landscape of high-risk neuroblastoma.\u201d Nature Genetics 45(3):279\u2013284. https:\/\/doi.org\/10.1038\/ng.2529","journal-title":"Nature Genetics"},{"issue":"5","key":"3_CR37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1158\/2159-8290.CD-16-0861","volume":"8","author":"P Rajbhandari","year":"2018","unstructured":"Rajbhandari P et al (2018) Cross-cohort analysis identifies a TEAD4\u2013MYCN positive feedback loop as the core regulatory element of high-risk neuroblastoma. Cancer Discov 8(5):582\u2013599. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0861","journal-title":"Cancer Discov"},{"issue":"16","key":"3_CR38","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.1021\/ACS.JMEDCHEM.9B01101\/ASSET\/IMAGES\/MEDIUM\/JM9B01101_M009.GIF","volume":"63","author":"R Rodr\u00edguez-P\u00e9rez","year":"2020","unstructured":"Rodr\u00edguez-P\u00e9rez R, Bajorath J (2020) Interpretation of compound activity predictions from complex machine learning models using local approximations and shapley values. J Med Chem 63(16):8761\u20138777. https:\/\/doi.org\/10.1021\/ACS.JMEDCHEM.9B01101\/ASSET\/IMAGES\/MEDIUM\/JM9B01101_M009.GIF","journal-title":"J Med Chem"},{"key":"3_CR39","doi-asserted-by":"publisher","unstructured":"Sahu D, Ho SY, Juan HF, Huang HC (2018) \u201cHigh-risk, Expression-Based Prognostic Long Noncoding RNA Signature in Neuroblastoma,\u201d JNCI Cancer Spectr 2(2) https:\/\/doi.org\/10.1093\/JNCICS\/PKY015.","DOI":"10.1093\/JNCICS\/PKY015"},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ng.2493","volume":"45","author":"M Sausen","year":"2012","unstructured":"Sausen M et al (2012) Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nature Genetics 45:1. https:\/\/doi.org\/10.1038\/ng.2493","journal-title":"Nature Genetics"},{"issue":"8","key":"3_CR41","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3349","volume":"47","author":"A Schramm","year":"2015","unstructured":"Schramm A et al (2015) Mutational dynamics between primary and relapse neuroblastomas. Nature Genetics 47(8):872\u2013877. https:\/\/doi.org\/10.1038\/ng.3349","journal-title":"Nature Genetics"},{"issue":"25","key":"3_CR42","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1200\/JCO.2013.54.0674\/SUPPL_FILE\/DATA_SUPPLEMENT_JCO.2013.54.0674.PDF","volume":"32","author":"G Schleiermacher","year":"2014","unstructured":"Schleiermacher G et al (2014) Emergence of new ALK mutations at relapse of neuroblastoma. J Clin Oncol 32(25):2727\u20132734. https:\/\/doi.org\/10.1200\/JCO.2013.54.0674\/SUPPL_FILE\/DATA_SUPPLEMENT_JCO.2013.54.0674.PDF","journal-title":"J Clin Oncol"},{"issue":"12","key":"3_CR43","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/S0959-8049(97)00293-1","volume":"33","author":"D Strother","year":"1997","unstructured":"Strother D et al (1997) Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group. Eur J Cancer 33(12):2121\u20132125. https:\/\/doi.org\/10.1016\/S0959-8049(97)00293-1","journal-title":"Eur J Cancer"},{"issue":"10","key":"3_CR44","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1002\/IJC.25436","volume":"127","author":"JH Schulte","year":"2010","unstructured":"Schulte JH et al (2010) Accurate prediction of neuroblastoma outcome based on miRNA expression profiles. Int J Cancer 127(10):2374\u20132385. https:\/\/doi.org\/10.1002\/IJC.25436","journal-title":"Int J Cancer"},{"key":"3_CR45","doi-asserted-by":"publisher","unstructured":"Tranchevent L et al (2018) \u201cPredicting clinical outcome of neuroblastoma patients using an integrative network-based approach,\u201d Biol Direct 13 https:\/\/doi.org\/10.1186\/s13062-018-0214-9.","DOI":"10.1186\/s13062-018-0214-9"},{"issue":"7","key":"3_CR46","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(09)70154-8","volume":"10","author":"J Vermeulen","year":"2009","unstructured":"Vermeulen J et al (2009) Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN\/COG\/GPOH study. Lancet Oncol 10(7):663\u2013671. https:\/\/doi.org\/10.1016\/S1470-2045(09)70154-8","journal-title":"Lancet Oncol"},{"issue":"3","key":"3_CR47","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/S00261-022-03774-0\/METRICS","volume":"48","author":"H Wang","year":"2023","unstructured":"Wang H et al (2023) Contrast-enhanced computed tomography radiomics in predicting primary site response to neoadjuvant chemotherapy in high-risk neuroblastoma. Abdominal Radiol 48(3):976\u2013986. https:\/\/doi.org\/10.1007\/S00261-022-03774-0\/METRICS","journal-title":"Abdominal Radiol"},{"issue":"1","key":"3_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12864-019-5997-2\/TABLES\/2","volume":"20","author":"L Wu","year":"2019","unstructured":"Wu L, Liu X, Xu J (2019) HetEnc: A deep learning predictive model for multi-type biological dataset. BMC Genomics 20(1):1\u201310. https:\/\/doi.org\/10.1186\/S12864-019-5997-2\/TABLES\/2","journal-title":"BMC Genomics"},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12859-016-1334-9","volume":"17","author":"Y Yuan","year":"2016","unstructured":"Yuan Y et al (2016) DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations. BMC Bioinformatics 17:243\u2013256","journal-title":"BMC Bioinformatics"},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3389\/fonc.2019.01361","volume":"9","author":"J-G Zhou","year":"2019","unstructured":"Zhou J-G et al (2019) Development and validation of an RNA-seq-based prognostic signature in neuroblastoma. Front Oncol 9:1361","journal-title":"Front Oncol"}],"container-title":["Journal of King Saud University Computer and Information Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44443-025-00003-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44443-025-00003-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44443-025-00003-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:45:25Z","timestamp":1763567125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44443-025-00003-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s44443-025-00003-8","relation":{},"ISSN":["1319-1578","2213-1248"],"issn-type":[{"type":"print","value":"1319-1578"},{"type":"electronic","value":"2213-1248"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"0.06","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"270"}}